Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study

Addiction Science & Clinical Practice

Study Protocol

Pablo Barrio¹  Sílvia Mondon¹  Magalí Andreu¹  Xavier Roca²  Pablo Bautista³  Mar Parejo³  Margarida Pla³  Carmen Cabezas⁴  Antonia Raich⁵  Jordi Bernabeu⁵  Joseph Guydish⁶  Joan Colom⁷  Josep M. Suelves⁸  Jordi Vilaplana⁹  Marta Enríquez^1,10  Ariadna Feliu^1,11  Yolanda Castellano^1,11  Esteve Fernández^1,12  Cristina Martínez^1,13  Judith Saura^1,14 

[1] Addictions Unit, Psychiatry Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain;Addictive Behaviors Unit, Psychiatry Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain;Department of Public Health, Maternal Health and Mental Health, School of Medicine and Health Sciences, Universitat de Barcelona, L’Hospitalet del Llobregat, Barcelona, Spain;Government of Catalonia, Public Health Secretariat, Barcelona, Spain;Mental Health Department, Althaia Xarxa Assistencial Universitària, Manresa, Barcelona, Spain;Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 94158, San Francisco, CA, USA;Public Health Agency of Catalonia, Barcelona, Spain;Public Health Agency of Catalonia, Barcelona, Spain;Universitat Oberta de Catalunya, Barcelona, Spain;Serra Húnter Fellow, Computer Science Department, Universitat de Lleida, Lleida, Spain;Tobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center On Tobacco Control, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain;Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain;Tobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center On Tobacco Control, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain;Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain;CIBER en Enfermedades Respiratorias, CIBERES), Madrid, Spain;Tobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center On Tobacco Control, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain;Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain;CIBER en Enfermedades Respiratorias, CIBERES), Madrid, Spain;Department of Clinical Sciences. School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain;Tobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center On Tobacco Control, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain;Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain;CIBER en Enfermedades Respiratorias, CIBERES), Madrid, Spain;Department of Public Health, Maternal Health and Mental Health, School of Medicine and Health Sciences, Universitat de Barcelona, L’Hospitalet del Llobregat, Barcelona, Spain;Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 94158, San Francisco, CA, USA;Tobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center On Tobacco Control, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain;Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain;Department of Public Health, Maternal Health and Mental Health, School of Medicine and Health Sciences, Universitat de Barcelona, L’Hospitalet del Llobregat, Barcelona, Spain;

关键词: Cannabis;    Alcohol;    Smoking cessation;    Substance abuse;   

DOI  :  10.1186/s13722-022-00348-9

 received in 2022-01-12, accepted in 2022-11-11,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundApproximately 80% of people with a substance use disorder (SUD) are smokers. Starting SUD treatment offers the opportunity to also quit smoking. The ACT-ATAC project aims to identify the predictors associated with smoking cessation among persons treated for alcohol and/or cannabis use disorder in Barcelona. This manuscript reports its methodology and the experience of carrying it out during the COVID-19 pandemic.MethodsMixed methods project with three substudies. Substudy 1 (S1) comprises heterogeneous discussion groups among clinicians. S2 has two prospective cohorts composed of smokers under treatment for alcohol and/or cannabis use disorder and the clinicians in charge of these patients. Participating smokers will be followed for 12 months and interviewed about their substance use and the tobacco cessation services received using the Spanish version of the users’ Knowledge, Attitudes, and Services (S-KAS) scale. The clinicians will be asked about their self-reported practices in smoking cessation using the Knowledge, Attitudes, and Practices (S-KAP) scale. S3 comprises heterogeneous discussion groups with smokers. Data will be triangulated using qualitative and quantitative analyses. To facilitate the recruitment process, the researchers have introduced several strategies (design clear protocols, set monthly online meetings, extend the project, provide gift cards, etc.).DiscussionThe results of S1 were used to develop the questionnaires. S2 required some adjustments due to the COVID-19 pandemic, particularly the follow-up interviews being conducted by phone instead of face-to-face, and the recruitment rhythm was lower than expected. Recruitment will last until reaching at least 200–250 users. The fieldwork could not have been possible without the collaboration of the ACT-ATAC team and the introduction of several strategies.Trial registration The ACT-ATAC project has been successfully registered at Clinicaltrials.gov [NCT04841655].

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

12982_2022_119_Article_IEq26.gif

12982_2022_119_Article_IEq21.gif

12982_2022_119_Article_IEq17.gif